3M

The test is the first to be approved for the company's second-generation molecular detection system, but can also be run using the first-generation system alongside other existing assays.

Bruker said the new agreement would allow it to develop the platform for use in pathology labs, including building clinically validated content libraries.

The 3M Molecular Detection Assay 2 – Listeria monocytogenes is 30 percent faster than the first-generation test.

Brainco Biopharma has been awarded

3M Food Safety said last week that its 3M Molecular Detection Assay Salmonella has received an extension of the current NF Validation certificate from ANFOR Certification.

NEW YORK (GenomeWeb News) – Bruker said today it has signed an exclusive patent license agreement with 3M Company that allows it to include in its products patented 3M technology related to MALDI mass spec imaging.

The UK's Medical Research Council has been awarded US Patent No. 8,435,775, "Mutant Pfu DNA polymerase."
Phillip Holliger, Nicola Ramsay, and Ann-Sofie Jemth are named as inventors.

UK-based molecular diagnostics developer Lumora has partnered with the Foundation for Innovative New Diagnostics to develop a rapid, high-throughput malaria diagnostic assay to screen patients in the developing world.

Evogen, a Lenexa, Kansas-based developer of molecular detection and diagnostic technologies, said this week that it has non-exclusively licensed its PCR probe technology to Focus Diagnostics, a Quest Diagnostics subsidiary.

Pages

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.